ELLICOTT CITY, Md., Oct. 12, 2016 /PRNewswire/ -- Two months after making the Informational Modules from TransCelerate's Site Qualification and Training (SQT) initiative available on the SCRS website, the success of the program is evident.
"The SQT Informational Modules are designed to provide clinical research education to sites," said Christine Pierre, President of SCRS. "SCRS partnered with TransCelerate to provide the Informational Modules to better serve the sites. So far the modules have been accessed more than 1,000 times by site personnel around the globe. SCRS is happy to offer these Informational Modules complementary to anyone, regardless of whether they are members of SCRS."
Katarina Hugeneck, SQT Initiative Leader for TransCelerate and Manager of Global Study Training at Eli Lilly and Company, explains, "The content within the Informational Programs was developed with the collective knowledge and expertise of TransCelerate Member Company personnel with contributions from sites staff representatives through an SCRS Site Advocacy Group. We believe that these readily available resources will prove to be beneficial to sites as they prepare to conduct clinical research, and represents an important step in improving the relationship between sites and clinical trial sponsors."
These solutions were created in accordance with the ICH Guideline for Good Clinical Practice: Consolidated Guidance (E6) and can be accessed through the SCRS website here.
SCRS is a global trade organization founded in 2012 which represents over 3,000 research sites in 49 countries. SCRS' mission is to unify the voice of the global clinical research site community for greater site sustainability. SCRS has become an active partner in industry-wide initiatives and dialogues focused on improving the clinical research enterprise. Sites and the companies that sponsor or support the work conducted at clinical research sites will benefit from membership and partnership. Visit MySCRS.org.
About TransCelerate BioPharma, Inc.
TransCelerate BioPharma Inc. is a non-profit organization dedicated to improving the health of people around the world by simplifying and accelerating the research and development (R&D) of innovative new therapies. The organizations' mission is to collaborate across the global biopharmaceutical R&D community to identify, prioritize, design and facilitate implementation of solutions designed to drive the efficient, effective and high quality delivery of new medicines. Membership in TransCelerate is open to pharmaceutical and biotechnology companies with Research & Development operations. Executive offices are located in Philadelphia, PA. For more information, please visit transceleratebiopharmainc.com.
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/scrs-announces-success-of-site-qualification-and-training-informational-modules-300342625.html
SOURCE Society for Clinical Research Sites